SMTL ID : 5v62.1

Phospho-ERK2 bound to bivalent inhibitor SBP3

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-1-1-mer

Ligands

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 2 residues within 4Å: Chain A: N.229, H.230 1 PLIP interactions: 1 interactions with chain A Water bridges: A:H.230 GOL.2: 2 residues within 4Å: Chain A: Y.178, Y.224 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.224 GOL.3: 2 residues within 4Å: Chain A: M.190, A.251 No protein-ligand interaction detected (PLIP) GOL.4: 7 residues within 4Å: Chain A: D.11, R.82, A.83, Q.88, M.89, K.90, D.91 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:D.11, A:A.83, A:K.90, A:D.91, A:D.91, A:D.91 GOL.5: 4 residues within 4Å: Chain A: D.170, H.171, F.174, F.322 2 PLIP interactions: 2 interactions with chain A Water bridges: A:H.169, A:D.170

1 x FRZ: 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE(Non-covalent)

FRZ.6: 14 residues within 4Å: Chain A: V.30, A.43, I.44, K.45, I.75, I.94, Q.96, D.97, L.98, M.99, N.145, L.147, D.158 Ligands: AKS.7 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.30, A:A.43, A:K.45, A:I.94, A:Q.96, A:L.147, A:D.158 Hydrogen bonds: A:K.45, A:Q.96, A:M.99

1 x AKS: N-(hex-5-yn-1-yl)hexanamide(Non-covalent)

AKS.7: 6 residues within 4Å: Chain A: L.98, M.99, E.100, T.101, K.105 Ligands: FRZ.6 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lechtenberg, B.C. et al., Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors. ACS Med Chem Lett (2017)

Release Date

2017-07-26

Peptides

Mitogen-activated protein kinase 1: A
Ribosomal protein S6 kinase alpha-1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
I

Mitogen-activated protein kinase 1

Ribosomal protein S6 kinase alpha-1